Curanex Pharmaceuticals Inc (CURX)
Curanex Pharmaceuticals will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $6.00
Shares Offered
2,000,000
Deal Size
$10.00M

Company Description

Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases.

Our mission is to address significant unmet medical needs and improve patients’ lives by harnessing the power of natural substances.

We are dedicated to discovering, developing and commercializing botanical medicines for treating patients with immune and inflammatory diseases and to develop therapies that may offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections.

Curanex Pharmaceuticals Inc
Country United States
Founded 2018
Industry Biotechnology
Sector Healthcare
CEO Jun Liu

Contact Details

Address:
2 Jericho Plaza, Suite 101B
Jericho, NY 11753
United States
Phone (718) 673-6078
Website curanexpharma.com

Stock Details

Ticker Symbol CURX
Exchange NASDAQ
Reporting Currency USD
CIK Code 0002025942
Employer ID 83-0741390
SIC Code 2834

Key Executives

Name Position
Jun Liu Chief Executive Officer, President and Director
Dian Ying Jing Director and Secretary
Haiyan Yang Chief Financial Officer and Treasurer
Huijuan Zhong Chief Science Officer
Liqin Xie Chief Operating Officer
Ning Zhang Chief Technology Officer
Yong Yan Independent Director
Yanming Du Independent Director
Xiaohui Hao Independent Director

Latest SEC Filings

Date Type Title
Nov 27, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Nov 1, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Oct 16, 2024 S-1 General form for registration of securities under the Securities Act of 1933